Etanercept in a Patient with Severe Psoriasis and Latent Viral Hepatic Disease and Latent Tuberculosis.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
Works matching IS 11750561 AND DT 2010 AND VI 11 AND IP S1
Results: 18
1
2
A Case of Severe Psoriasis with an Apparent Incomplete Response to Anti-Tumour Necrosis Factor Alpha Treatment.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
3
Onset of Lichen Planus During Treatment with Etanercept.
- Published in:
- American Journal of Clinical Dermatology, 2010, v. 11, n. S1, p. 55, doi. 10.2165/1153428-S0-000000000-00000
- By:
- Publication type:
- Article
4
A Case of Dystiophic Epidermolysis Bullosa Improved with Etanercept for Concomitant Psoriatic Arthritis.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
5
Etanercept Therapy for Psoriasis in a Patient with Numerous Comorbidities.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
6
A Patient with Psoriasis and Vitiligo Treated with Etanercept.
- Published in:
- American Journal of Clinical Dermatology, 2010, v. 11, n. S1, p. 46, doi. 10.2165/1153424-S0-000000000-00000
- By:
- Publication type:
- Article
7
Beneficial Neurological Effects Observed in a Patient with Psoriasis Treated with Etanercept.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
8
Etanercept Therapy for Psoriasis in a Patient with Active Pulmonary Tuberculosis.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
9
Nicolau Syndrome Following Etanercept Administration.
- Published in:
- American Journal of Clinical Dermatology, 2010, v. 11, n. S1, p. 51, doi. 10.2165/1153426-S0-000000000-00000
- By:
- Publication type:
- Article
10
Adverse Effects of Biological Agents in the Treatment of Psoriasis.
- Published in:
- American Journal of Clinical Dermatology, 2010, v. 11, n. S1, p. 35, doi. 10.2165/1153420-S0-000000000-00000
- By:
- Publication type:
- Article
11
Biological Agents for Controlling Excessive Scarring.
- Published in:
- American Journal of Clinical Dermatology, 2010, v. 11, n. S1, p. 31, doi. 10.2165/1153419-S0-000000000-00000
- By:
- Publication type:
- Article
12
The Role of Biological Agents in the Treatment of Nail Psoriasis.
- Published in:
- American Journal of Clinical Dermatology, 2010, v. 11, n. S1, p. 27, doi. 10.2165/1153418-S0-000000000-00000
- By:
- Publication type:
- Article
13
Biological Agents for Chronic Wounds.
- Published in:
- American Journal of Clinical Dermatology, 2010, v. 11, n. S1, p. 23, doi. 10.2165/1153417-S0-000000000-00000
- By:
- Publication type:
- Article
14
Psoriatic Arthritis: A Dermatologist's Perspective.
- Published in:
- American Journal of Clinical Dermatology, 2010, v. 11, n. S1, p. 19, doi. 10.2165/1153416-S0-000000000-00000
- By:
- Publication type:
- Article
15
Managing Pediatric Patients with Psoriasis.
- Published in:
- American Journal of Clinical Dermatology, 2010, v. 11, n. S1, p. 15, doi. 10.2165/1153415-S0-000000000-00000
- By:
- Publication type:
- Article
16
Psoriasis: Targeting Therapy Towards the Inflammatory Cascade.
- Published in:
- American Journal of Clinical Dermatology, 2010, v. 11, n. S1, p. 11, doi. 10.2165/1153414-S0-000000000-00000
- By:
- Publication type:
- Article
17
Etanercept: An Evolving Role in Psoriasis and Psoriatic Arthritis.
- Published in:
- American Journal of Clinical Dermatology, 2010, v. 11, n. S1, p. 3, doi. 10.2165/1153413-S0-000000000-00000
- By:
- Publication type:
- Article
18
FOREWORD.
- Published in:
- American Journal of Clinical Dermatology, 2010, v. 11, n. S1, p. 1, doi. 10.2165/1153412-S0-000000000-00000
- By:
- Publication type:
- Article